Association Between GLP‐1RAs and Risk of VTE Events We observed an increasing trend in the risk of VTE among participants using GLP‐1RAs; however, this increase was not statistically significant (OR, 1.19 [95% CI, 0.94–1.50]) (Figure 2 ; Table 2 ).
← all excerpts
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
1
—
—